COX-2 inhibitors: cancer prevention or cardiovascular risk?

被引：13
|
作者：
Senior, K
机构：
来源：
LANCET ONCOLOGY | 2005年 / 6卷 / 02期
关键词：
D O I：
10.1016/S1470-2045(05)01720-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：68 / 68
页数：1
相关论文
共 50 条
  • [1] COX-2 inhibitors and cardiovascular risk
    Funk, Colin D.
    FitzGerald, Garret A.
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2007, 50 (05) : 470 - 479
  • [2] COX-2 Inhibitors and Cardiovascular Risk
    Cannon, Christopher P.
    Cannon, Paul J.
    [J]. SCIENCE, 2012, 336 (6087) : 1386 - 1387
  • [3] Cox-2: where are we in 2003? - Cardiovascular risk and Cox-2 inhibitors
    Debabrata Mukherjee
    Eric J Topol
    [J]. Arthritis Res Ther, 5
  • [4] COX-2 Inhibitors for the Prevention of Breast Cancer
    Louise R. Howe
    Andrew J. Dannenberg
    [J]. Journal of Mammary Gland Biology and Neoplasia, 2003, 8 : 31 - 43
  • [5] COX-2 inhibitors for the prevention of breast cancer
    Howe, LR
    Dannenberg, AJ
    [J]. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA, 2003, 8 (01) : 31 - 43
  • [6] Risk of cardiovascular events associated with COX-2 inhibitors
    不详
    [J]. HOSPITAL MEDICINE, 2001, 62 (09): : 577 - 577
  • [7] Are COX-2 inhibitors a risk factor for cardiovascular disease?
    John, S
    Schmieder, RE
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2002, 127 (04) : 156 - 159
  • [8] Cardiovascular Risk Associated With NSAIDs and COX-2 Inhibitors
    Perry, Laura A.
    Mosier, Charles
    Atkins, Ashton
    Minehart, Megan
    [J]. US PHARMACIST, 2014, 39 (03) : 35 - 38
  • [9] COX-2 inhibitors and cardiovascular risk - Point and counterpoint
    Mandell, BF
    [J]. CLEVELAND CLINIC JOURNAL OF MEDICINE, 2001, 68 (11) : 957 - 960
  • [10] Rofecoxib, selective COX-2 inhibitors and cardiovascular risk
    Dhaun, N.
    Maxwell, S. R. J.
    Webb, D. J.
    [J]. JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF EDINBURGH, 2005, 35 (02): : 101 - 103
12345